Michael Heffernan, R. Ph
2018
In 2018, Michael Heffernan, R. Ph earned a total compensation of $4.6M as Founder and Chairman at Collegium Pharmaceutical, a 63% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $222,495 |
|---|---|
| Option Awards | $2,217,803 |
| Salary | $317,308 |
| Stock Awards | $1,826,250 |
| Other | $60,186 |
| Total | $4,644,042 |
Ph received $2.2M in option awards, accounting for 48% of the total pay in 2018.
Ph also received $222.5K in non-equity incentive plan, $317.3K in salary, $1.8M in stock awards and $60.2K in other compensation.
Rankings
In 2018, Michael Heffernan, R. Ph's compensation ranked 2,233rd out of 14,244 executives tracked by ExecPay. In other words, Ph earned more than 84.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,233 out of 14,244 | 84th |
Division Manufacturing | 813 out of 5,762 | 86th |
Major group Chemicals And Allied Products | 271 out of 2,125 | 87th |
Industry group Drugs | 219 out of 1,814 | 88th |
Industry Pharmaceutical Preparations | 170 out of 1,388 | 88th |
Source: SEC filing on March 15, 2019.
Ph's colleagues
We found five more compensation records of executives who worked with Michael Heffernan, R. Ph at Collegium Pharmaceutical in 2018.
2018
Joseph Ciaffoni
Collegium Pharmaceutical
Chief Executive Officer
2018
Scott Dreyer
Collegium Pharmaceutical
Executive Vice President and Chief Commercial Officer
2018
Paul Brannelly
Collegium Pharmaceutical
Chief Financial Officer
2018
Alison Fleming
Collegium Pharmaceutical
Chief Technology Officer
2018
Shirley Kuhlmann
Collegium Pharmaceutical